Advisors Asset Management Inc. Sells 560 Shares of McKesson Corporation $MCK

Advisors Asset Management Inc. trimmed its position in shares of McKesson Corporation (NYSE:MCK) by 7.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,778 shares of the company’s stock after selling 560 shares during the period. Advisors Asset Management Inc.’s holdings in McKesson were worth $5,236,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in MCK. Brighton Jones LLC lifted its stake in shares of McKesson by 46.3% during the 4th quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock worth $1,438,000 after acquiring an additional 798 shares during the last quarter. Caxton Associates LLP purchased a new stake in McKesson in the first quarter worth $233,000. Sivia Capital Partners LLC lifted its position in shares of McKesson by 77.9% during the second quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock worth $502,000 after purchasing an additional 300 shares during the last quarter. Concurrent Investment Advisors LLC boosted its stake in shares of McKesson by 11.9% during the second quarter. Concurrent Investment Advisors LLC now owns 1,987 shares of the company’s stock valued at $1,456,000 after purchasing an additional 211 shares during the period. Finally, Axxcess Wealth Management LLC grew its holdings in shares of McKesson by 65.4% in the second quarter. Axxcess Wealth Management LLC now owns 898 shares of the company’s stock worth $658,000 after purchasing an additional 355 shares during the last quarter. Institutional investors own 85.07% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently weighed in on MCK. Barclays began coverage on shares of McKesson in a report on Monday, December 8th. They set an “overweight” rating and a $960.00 price objective for the company. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of McKesson in a research note on Wednesday, December 10th. JPMorgan Chase & Co. increased their price objective on McKesson from $983.00 to $1,107.00 and gave the stock an “overweight” rating in a research note on Tuesday. Mizuho lifted their target price on McKesson from $880.00 to $885.00 and gave the company a “neutral” rating in a research report on Thursday, February 5th. Finally, Weiss Ratings cut McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, McKesson has an average rating of “Moderate Buy” and an average price target of $937.07.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Thomas L. Rodgers sold 276 shares of McKesson stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $816.18, for a total transaction of $225,265.68. Following the completion of the sale, the executive vice president owned 2,268 shares of the company’s stock, valued at approximately $1,851,096.24. The trade was a 10.85% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the business’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The disclosure for this sale is available in the SEC filing. Insiders own 0.08% of the company’s stock.

McKesson Stock Performance

Shares of NYSE MCK opened at $916.08 on Friday. McKesson Corporation has a fifty-two week low of $585.22 and a fifty-two week high of $971.93. The company has a market cap of $112.21 billion, a PE ratio of 26.35, a P/E/G ratio of 1.53 and a beta of 0.40. The business has a 50-day simple moving average of $837.61 and a two-hundred day simple moving average of $785.95.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.19 by $0.15. The firm had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company’s revenue for the quarter was up 11.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, sell-side analysts predict that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be paid a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Monday, March 2nd. McKesson’s payout ratio is presently 9.43%.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.